Selective estrogen-receptor modulators for primary prevention of breast cancer

被引：71

作者：

Fabian, CJ

Kimler, BF

机构：

[1] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66160 USA

[2] Univ Kansas, Med Ctr, Dept Radiat Oncol, Kansas City, KS 66160 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 08期

关键词：

D O I：

10.1200/JCO.2005.11.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1644 / 1655

页数：12

共 207 条

[81] Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer [J].

Gail, MH ;

Costantino, JP ;

Bryant, J ;

Croyle, R ;

Freedman, L ;

Helzlsouer, K ;

Vogel, V .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (21) :1829-1846

[82]

Galvez AF, 2001, CANCER RES, V61, P7473

[83]

Ganz PA, 2002, J NATL CANCER I, V94, P547

[84] The clinical application of targeting cancer through histone acetylation and hypomethylation [J].

Gilbert, J ;

Gore, SD ;

Herman, JG ;

Carducci, MA .

CLINICAL CANCER RESEARCH, 2004, 10 (14) :4589-4596

[85]

Goldstein SR, 1998, AM J OBSTET GYNECOL, V179, P1479, DOI 10.1016/S0002-9378(98)70012-2

[86] A pharmacological review of selective oestrogen receptor modulators [J].

Goldstein, SR ;

Siddhanti, S ;

Ciaccia, AV ;

Plouffe, L .

HUMAN REPRODUCTION UPDATE, 2000, 6 (03) :212-224

[87]

Gradishar W, 2000, CANCER, V88, P2047, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2047::AID-CNCR10>3.0.CO

[88]

2-E

[89] Molecular determinants of tissue selectivity in estrogen receptor modulators [J].

Grese, TA ;

Sluka, JP ;

Bryant, HU ;

Cullinan, GJ ;

Glasebrook, AL ;

Jones, CD ;

Matsumoto, K ;

Palkowitz, AD ;

Sato, M ;

Termine, JD ;

Winter, MA ;

Yang, NN ;

Dodge, JA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (25) :14105-14110

[90] THE EFFECT OF THE ANTIESTROGEN TAMOXIFEN ON CARDIOVASCULAR RISK-FACTORS IN NORMAL POSTMENOPAUSAL WOMEN [J].

GREY, AB ;

STAPLETON, JP ;

EVANS, MC ;

REID, IR .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (11) :3191-3195

← 4 5 6 7 8 9 10 11 12 13 →